Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer

BACKGROUND: Patients with brain metastases from lung cancer have poor prognoses and short survival time, and they are often excluded from clinical trials. Whole-cranial irradiation is considered to be the standard treatment, but its efficacy is not satisfactory. The purpose of this phase II clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Xiao-hui, Lin, Qiang, Ren, Xiao-cang, Liu, Yue-e, Chen, Xue-ji, Wang, Dong-ying, Wang, Yong-qiang, Cao, Bin, Li, Zhi-gang, Liu, Miao-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853318/
https://www.ncbi.nlm.nih.gov/pubmed/24125485
http://dx.doi.org/10.1186/1748-717X-8-238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853318/
https://www.ncbi.nlm.nih.gov/pubmed/24125485
http://dx.doi.org/10.1186/1748-717X-8-238

Ejemplares similares